UB Paderborn / Katalog / Suche / in CDI

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

European journal of cancer (1990), 2004-07, Vol.40 (11), p.1704-1712

2004

Volltextzugriff (PDF)

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

Annals of oncology, 2009-07, Vol.20 (7), p.1203-1209

2009

Volltextzugriff (PDF)

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

The lancet oncology, 2020-04, Vol.21 (4), p.581-592

2020

Volltextzugriff (PDF)

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Annals of oncology, 1997-06, Vol.8 (6), p.525-529

1997

Volltextzugriff (PDF)

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2003-09, Vol.14 (9), p.1399-1405

2003

Volltextzugriff (PDF)

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2004-01, Vol.15 (1), p.180-180

2004

Volltextzugriff (PDF)

Bone effects of exemestane vs. tamoxifen within the TEAM trial: results of a prospective randomized bone sub study

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.1143

2009

Volltextzugriff (PDF)

Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.572-572

2008

Volltextzugriff (PDF)

Nebenwirkungen der kurativen Strahlentherapie des lokal begrenzten Prostatacarzinoms unter Einsatz der HDR- Brachytherapie mit Iridium192

Aktuelle Urologie, 2006, Vol.37 (S 1)

2006

Volltextzugriff (PDF)

2452

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S460-S461

2006

Volltextzugriff (PDF)

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer

Seminars in oncology, 1997-06, Vol.24 (3 Suppl 8), p.S8

1997

Volltextzugriff (PDF)

2452: Phase II Study of Combined Radiotherapy and Temozolomide in Patients With Cerebral Metastases From Lung Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S460-S461

2006

Volltextzugriff (PDF)

Simultaneous radiochemotherapy with paclitaxel in non-small cell lung cancer: a clinical phase I study

Seminars in oncology, 1996-12, Vol.23 (6 Suppl 15), p.26

1996

Volltextzugriff (PDF)

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 1999-11, Vol.26 (2), p.85-94

1999

Volltextzugriff (PDF)

Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: Updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy

Annals of oncology, 1991-02, Vol.2 (suppl-2), p.177-180

1991

Volltextzugriff (PDF)

Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study

International journal of radiation oncology, biology, physics, 1997-09, Vol.39 (2), p.321-326

1997

Volltextzugriff (PDF)

Gemcitabine (G) followed by 2nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II study

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.11-12

2000

Volltextzugriff (PDF)

Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs, des Zungengrundes und des Hypopharynx - Teil 2: Bestrahlungstherapie und Spätresultate nach chirurgisch-radiologischer Kombinationsbehandlung

Laryngo- rhino- otologie, 1991-06, Vol.70 (6), p.307-311

1991

Volltextzugriff (PDF)

Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs, des Zungengrundes und des Hypopharynx. II, Bestrahlungstherapie und Spätresultate nach chirurgisch-radiologischer Kombinationsbehandlung

Laryngo- rhino- otologie, 1991, Vol.70 (6), p.307-311

1991

Volltextzugriff (PDF)

Gemcitabine (G) followed by 2 nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II study

Lung cancer (Amsterdam, Netherlands), 2000, Vol.29 (1), p.11-12

2000

Volltextzugriff (PDF)

Die primär kurative Strahlentherapie kleiner Stimmbandkarzinome

Laryngo- rhino- otologie, 1990-06, Vol.69 (6), p.308-311

1990

Volltextzugriff (PDF)

Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate

European journal of cancer (1990), 1999-09, Vol.35, p.S83-S83

1999

Volltextzugriff (PDF)

Radiotherapy in Stage IIA and IIB Testicular Seminoma With Reduced Portals: A Prospective Multicenter Study

The Journal of urology, 1998-06, Vol.159 (6), p.2239-2239

1998

Volltextzugriff (PDF)

Radiotherapy in Stage IIA and IIB Testicular Seminoma With Reduced Portals: A Prospective Multicenter Study

The Journal of urology, 1998-06, p.2239

1998

Volltextzugriff (PDF)

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer: Recent developments and future directions for research with gemcitabine HCl in the treatment of lung cancer: part 2

Seminars in oncology, 1997, Vol.24 (3), p.S8-13

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Bone effects of exemestane vs. tamoxifen within the TEAM trial: results of a prospective randomized bone sub study

Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy

Nebenwirkungen der kurativen Strahlentherapie des lokal begrenzten Prostatacarzinoms unter Einsatz der HDR- Brachytherapie mit Iridium192

2452

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer

2452: Phase II Study of Combined Radiotherapy and Temozolomide in Patients With Cerebral Metastases From Lung Cancer

Simultaneous radiochemotherapy with paclitaxel in non-small cell lung cancer: a clinical phase I study

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: Updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy

Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study

Gemcitabine (G) followed by 2nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II study

Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs, des Zungengrundes und des Hypopharynx - Teil 2: Bestrahlungstherapie und Spätresultate nach chirurgisch-radiologischer Kombinationsbehandlung

Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs, des Zungengrundes und des Hypopharynx. II, Bestrahlungstherapie und Spätresultate nach chirurgisch-radiologischer Kombinationsbehandlung

Gemcitabine (G) followed by 2 nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II study

Die primär kurative Strahlentherapie kleiner Stimmbandkarzinome

Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate

Radiotherapy in Stage IIA and IIB Testicular Seminoma With Reduced Portals: A Prospective Multicenter Study

Radiotherapy in Stage IIA and IIB Testicular Seminoma With Reduced Portals: A Prospective Multicenter Study

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer: Recent developments and future directions for research with gemcitabine HCl in the treatment of lung cancer: part 2

Suchergebnisse filtern